IVD Quality Control Market Research Report 2023: Technological Advancements Spruce up Immunoassays and Clinical Chemistry – Global Forecast to 2030

DUBLIN, Jan. 19, 2024 /PRNewswire/ — The “IVD Quality Control Market by Offering, Application, and End User – Global Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.

The global In-Vitro Diagnostics (IVD) Quality Control Market is projected to witness substantial growth, reaching an estimated value of $2.19 billion by the year 2030, expanding at a Compound Annual Growth Rate (CAGR) of 4.3% from 2023 to 2030. This significant market expansion is attributed to the heightened demand for quality assurance in diagnostic testing across various healthcare sectors.

IVD Quality Control Gains Traction as Chronic Diseases Rise

The market sees a positive trajectory, spurred by the burgeoning prevalence of chronic conditions, an aging population demographic, and a spike in the number of clinical labs. Quality control plays a pivotal role in ensuring the accuracy and reliability of patient test results, which is crucial in the effective management and treatment of diseases. As the healthcare industry embraces Point-of-Care (POC) testing and rapid diagnostics, the demand for robust quality control measures intensifies.

Technological Advancements Spruce up Immunoassays and Clinical Chemistry

Technological innovations within the immunoassay and clinical chemistry segments underpin the market’s growth. These advancements contribute to the development of sophisticated quality control solutions that enhance the efficacy of diagnostic procedures.

Moreover, infectious disease testing, particularly for conditions like hepatitis and sexually transmitted infections (STIs), necessitates precise IVD controls. The World Health Organization’s report on the rise of STIs underscores the critical nature of dependable diagnostics, thereby elevating the market demand.

Hospitals and Clinics: Largest End Users of IVD Quality Control

Among end users, hospitals, and clinics are anticipated to hold the lion’s share of the market in 2023. The high volume of diagnostic testing carried out in these settings, coupled with increasing healthcare-associated infections (HAIs) and subsequent medical spending, substantiates this demand.

Geographical Market Analysis Highlights North America’s Dominance

The North America region is estimated to be at the forefront of the IVD Quality Control Market in 2023, trailed by Europe and the Asia-Pacific. Factors such as the widespread prevalence of chronic and infectious diseases, heightened awareness of early disease diagnosis, and the influx of cutting-edge diagnostic products fortify the region’s market position.

Offerings in the Spotlight: The report delves into quality control products—serum/plasma-based controls, whole blood-based controls, and other types including urine-based controls—emphasizing independent controls and instrument-specific controls. Quality assessment services and data management solutions are also examined.Applications and Technologies: A thorough examination of the market is presented across various applications such as infectious diseases, oncology, cardiology, and more. It covers a wide array of technologies from immunochemistry to molecular diagnostics and microbiology.Revenue Forecasts and Trends: The report includes a detailed analysis of revenue forecasts, market trends, and growth opportunities, setting the scene for stakeholders and industry participants to understand the market dynamics.

This comprehensive market analysis underscores the crucial role of IVD quality control in the healthcare landscape. It is instrumental in ensuring the delivery of high-standard diagnostic services that are pivotal for patient care and treatment outcomes.

The report is an indispensable resource for industry professionals, offering key insights into market trends, forecasts, and the factors shaping the future of IVD quality controls.

Company Profiles

Seimens Healthineers AG (Germany)Bio-Rad Laboratories Inc. (U.S.)Danaher Corporation (U.S.)LGC Group (U.K.)Thermo Fisher Scientific Inc. (U.S.)SERO AS (Norway)Randox Laboratories Ltd. (U.K.)QuidelOrtho Corporation (U.S.)Streck LLC (U.S.)Microbiologics Inc. (U.S.)

Scope of the Report:

IVD Quality Control Market Assessment – by Offering

Quality Control ProductsQuality Control Products, by TypeSerum/Plasma-based ControlsWhole Blood-based ControlsUrine-based ControlsOther ControlsQuality Control Products, by FunctionIndependent ControlsInstrument-Specific ControlsQuality Assessment ServicesData Management Solutions

IVD Quality Control Market Assessment – by Technology

Immunoassay/ImmunochemistryBiochemistry/Clinical ChemistryMolecular DiagnosticsHematologyCoagulation/HemostasisMicrobiology

IVD Quality Control Market Assessment – by Application

Infectious DiseasesOncologyCardiologyAutoimmune DisordersNeurology

IVD Quality Control Market Assessment – by End User

Hospitals & ClinicsDiagnostic LaboratoriesAcademic Institutes & Research Laboratories

IVD Quality Control Market Assessment – by Geography

North AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalySpainRest of EuropeAsia-PacificChinaJapanIndiaRest of Asia-PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/7ly011

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/ivd-quality-control-market-research-report-2023-technological-advancements-spruce-up-immunoassays-and-clinical-chemistry—global-forecast-to-2030-302039264.html

SOURCE Research and Markets